Stifel Financial Corp Paratek Pharmaceuticals, Inc. Transaction History

Stifel Financial Corp

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$2.94 - $4.77 $128,692 - $208,797	-43,773 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.07 - $5.3 $284,081 - $369,934	-69,799 Reduced 61.46%	43,773 $197,000
Q3 2021 Nov 15, 2021	SELL	$4.7 - $7.24 $129,926 - $200,142	-27,644 Reduced 19.58%	113,572 $552,000
Q2 2021 Aug 13, 2021	SELL	$6.81 - $10.93 $153,749 - $246,766	-22,577 Reduced 13.78%	141,216 $963,000
Q1 2021 May 14, 2021	SELL	$6.14 - $8.31 $209,331 - $283,312	-34,093 Reduced 17.23%	163,793 $1.16 Million
Q4 2020 Feb 12, 2021	SELL	$4.58 - $7.14 $79,389 - $123,764	-17,334 Reduced 8.05%	197,886 $1.24 Million
Q3 2020 Nov 16, 2020	SELL	$4.19 - $6.69 $12,163 - $19,421	-2,903 Reduced 1.33%	215,220 $1.16 Million
Q2 2020 Aug 14, 2020	SELL	$2.97 - $5.22 $175,081 - $307,719	-58,950 Reduced 21.28%	218,123 $1.14 Million
Q1 2020 May 14, 2020	BUY	$2.67 - $4.97 $159,957 - $297,747	59,909 Added 27.59%	277,073 $872,000
Q4 2019 Feb 13, 2020	BUY	$2.93 - $4.5 $201,126 - $308,898	68,644 Added 46.22%	217,164 $874,000
Q3 2019 Nov 13, 2019	SELL	$3.08 - $5.76 $139,222 - $260,363	-45,202 Reduced 23.33%	148,520 $637,000
Q2 2019 Aug 14, 2019	BUY	$3.47 - $6.32 $296,240 - $539,551	85,372 Added 78.79%	193,722 $774,000
Q1 2019 May 14, 2019	BUY	$5.36 - $7.24 $486,956 - $657,754	90,850 Added 519.14%	108,350 $578,000
Q4 2018 Feb 13, 2019	BUY	$4.8 - $11.6 $84,000 - $203,000	17,500 New	17,500 $90,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.